The University of Maryland Marlene and Stewart Greenebaum Cancer Center's physicians and researchers work every day to advance the state-of-the-art in cancer treatment.
Their groundbreaking work in the cancer center's laboratories and clinics has contributed to the discovery of new ways to treat and care for cancer patients.
To learn about some of the recent news-making advances in cancer research and treatment at UMGCC during 2012, select from and click on the news stories below.
|2013 News Releases|
|6/2||Bevacizumab (Avastin) as Adjuvant in Newly Diagnosed Glioblastoma Fails to Improve Survival|
|5/15||Adam Callaway of Baltimore County Finishes First in Maryland Half Marathon|
|5/31||ASCO Presentations 2013|
|4/19||University of Maryland Greenebaum Cancer Center Advances Radiation Delivery to Cancer Patients With New Treatment Planning System|
|3/27||UM Breast Cancer Research Pioneer Dr. Angela Brodie Appointed Fellow of New American Association for Cancer Research Academy|
|3/25||World-Renowned Oncologist Kevin J. Cullen, M.D., Named First Marlene and Stewart Greenebaum Distinguished Professor in Oncology|
|3/20||UMGCC Named One of "100 Hospitals and Health Systems With Great Oncology Programs"|
|3/19||University of Maryland School of Medicine Researchers Identify Fish Peptide That May Inhibit Cancer Metastasis|
|Click here to see the 2012 news release archives.|